Semaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabetes. It works by stimulating the ...

In a significant stride towards combating metabolic dysfunction-associated steatohepatitis (MASH), Boehringer Ingelheim unveils groundbreaking re ...

May same-store sales increased 4.7% year-over-year NEWARK, N.J., June 07, 2024 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through ...

However, according to industry observers, investors considering exposure through the newly launched weight-loss ...

Turbocharging the GLP-1 agonist used to treat diabetes and obesity may transform treatment for patients with fatty liver ...

Both Eli Lilly and the partnered companies Boehringer Ingelheim and Zealand Pharma have mid-stage data readouts this week, ...